Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Canada. Founded in 2013, the company has rapidly evolved, focusing on developing and marketing a diverse range of innovative healthcare products, particularly in the fields of eye health, dermatology, and gastrointestinal health.
With a strong operational presence across North America and Europe, Bausch Health is recognised for its commitment to improving patient outcomes through unique therapies and solutions. The company’s core offerings include prescription medications, over-the-counter products, and medical devices, distinguished by their quality and efficacy. Bausch Health has achieved significant milestones, positioning itself as a leader in the pharmaceutical sector, dedicated to advancing health and wellness globally.
-3 vs industry average
Bausch Health Cos’s score of 39 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Bausch Health Cos, a Pharmaceutical Preparation Manufacturing company headquartered in CA, reported its 2023 climate impact, with Scope 1 emissions of approximately 49,906,000 kg CO2e and market-based Scope 2 emissions of around 51,990,000 kg CO2e. The company also reported Scope 3 emissions from waste generated in operations at approximately 27,107,000 kg CO2e for the same year. For 2022, Scope 1 emissions were approximately 46,686,000 kg CO2e, market-based Scope 2 emissions were around 50,513,000 kg CO2e, and Scope 3 emissions from waste generated in operations were approximately 19,260,000 kg CO2e.
Bausch Health Cos has an independently verified Science Based Target initiative (SBTi) commitment. This target, approved for BHC Ltd using a streamlined validation route for Small and Medium-sized Enterprises (SMEs), commits to reducing Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, against a 2020 base year. Additionally, the company is committed to measuring and reducing its Scope 3 emissions.
2030
42% reduction in Scope 1
This target was approved using a streamlined target validation route exclusive to small and medium-sized enterprises (SMEs). https://science…
2030
42% reduction in Scope 2
This target was approved using a streamlined target validation route exclusive to small and medium-sized enterprises (SMEs). https://science…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Bausch Health Cos’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more